Cumberland Pharmaceuticals Announces ASSIST-SSc Trial Top-Line Results
Ifetroban was well tolerated in patients with systemic sclerosis NASHVILLE, Tenn., Oct. 23, 2026 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), an innovation-driven biopharmaceutical company advancing new therapies that address significant unmet medical needs, announces...
Covered in this story
Call it yourself
No calls on $TOP yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on TOP Financial Group →Dalsna Finance is currently tracking 33 stories mentioning TOP Financial Group, the earliest published 4 Oct 2026.
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.